UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
January
22, 2020
Barclays PLC
(Name
of Registrant)
1 Churchill Place
London E14 5HP
England
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual
reports
under
cover of Form 20-F or Form 40-F.
Form
20-F x Form 40-F
Indicate
by check mark whether the registrant by furnishing the
information
contained
in this Form is also thereby furnishing the information to
the
Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes No
x
If
"Yes" is marked, indicate below the file number assigned to the
registrant
in
connection with Rule 12g3-2(b):
This
Report on Form 6-K is filed by Barclays PLC.
This
Report comprises:
Information
given to The London Stock Exchange and furnished pursuant
to
General
Instruction B to the General Instructions to Form 6-K.
EXHIBIT
INDEX
__________________________________________________________________________________
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
BARCLAYS
PLC
|
|
|
(Registrant)
|
Date:
January 22, 2020
|
|
By: /s/
Garth Wright
--------------------------------
|
|
|
Garth
Wright
|
|
|
Assistant
Secretary
|
22 January 2020
Barclays PLC
Barclays Non-executive Director appointment
Barclays PLC has appointed Dr. Brian Gilvary as a Non-executive
Director. He will take up his appointment with effect from 1
February 2020.
Dr. Gilvary has served as Chief Financial Officer for BP p.l.c.
since 2012. He joined BP in 1986 after obtaining a PhD in
Mathematics. After a variety of commercial and
financial roles internationally in BP's upstream, downstream and
trading businesses, he became chief executive of BP's integrated
supply and trading function in 2005 and in 2010 deputy CFO and head
of finance. He will retire from BP on 30 June
2020.
His experience outside BP includes serving as a non-executive
director and audit committee member of Air Liquide S.A., the Royal
Navy, and the Francis Crick Institute. Currently, he is Chairman of
'The 100 Group' of the FTSE 100 Finance Directors.
As a member of the Board, Dr. Gilvary will bring to Barclays his
extensive experience of management, finance and strategy gained at
BP and other public and private Boards. Dr. Gilvary's experience
with and understanding of the challenges and opportunities inherent
in the energy transition, including the acceleration of key
renewable options and developing key capital intensive clean energy
technologies, will be invaluable as Barclays considers how it can
help to accelerate the transition to a low carbon
world.
There is no additional information required to be disclosed in
relation to Dr. Brian Gilvary pursuant to paragraph LR9.6.13R of
the Listing Rules of the Financial Conduct Authority.
- Ends -
For further information, please contact:
|
Investor
Relations
|
Media
Relations
|
|
Adam
Strachan
|
Tom
Hoskin
|
|
+1 212
526 8442
|
+44 (0)
20 7116 4755
|
|
|
|
|
James
Johnson
|
|
|
+44
(0)20 7116 7233
|
|
About Barclays
Barclays is a British universal bank. We are diversified by
business, by different types of customer and client, and
geography. Our businesses include consumer banking and
payments operations around the world, as well as a top-tier, full
service, global corporate and investment bank, all of which are
supported by our service company which provides technology,
operations and functional services across the Group.